Clear Investment Research LLC grew its position in shares of Johnson & Johnson (NYSE:JNJ – Get Rating) by 3.4% during the fourth quarter, Holdings Channel reports. The institutional investor owned 2,215 shares of the company’s stock after purchasing an additional 72 shares during the quarter. Johnson & Johnson accounts for 0.8% of Clear Investment Research LLC’s holdings, making the stock its 26th largest holding. Clear Investment Research LLC’s holdings in Johnson & Johnson were worth $391,000 as of its most recent SEC filing.
A number of other institutional investors have also recently made changes to their positions in the company. Glassy Mountain Advisors Inc. bought a new stake in shares of Johnson & Johnson during the 4th quarter valued at $35,000. Retirement Financial Solutions LLC purchased a new position in shares of Johnson & Johnson during the 4th quarter valued at about $40,000. TD Capital Management LLC purchased a new position in shares of Johnson & Johnson during the 3rd quarter valued at about $48,000. VitalStone Financial LLC bought a new position in Johnson & Johnson during the 4th quarter worth approximately $52,000. Finally, Iron Horse Wealth Management LLC grew its position in Johnson & Johnson by 112.8% during the 4th quarter. Iron Horse Wealth Management LLC now owns 300 shares of the company’s stock worth $53,000 after acquiring an additional 159 shares during the last quarter. Hedge funds and other institutional investors own 67.94% of the company’s stock.
Analysts Set New Price Targets
Several equities analysts recently issued reports on the company. Raymond James reduced their price target on Johnson & Johnson from $185.00 to $181.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 19th. Atlantic Securities cut their price objective on Johnson & Johnson from $168.00 to $167.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 19th. Morgan Stanley lifted their price objective on Johnson & Johnson from $179.00 to $183.00 and gave the stock an “equal weight” rating in a research report on Wednesday, April 19th. UBS Group began coverage on Johnson & Johnson in a research report on Tuesday, March 28th. They issued a “neutral” rating and a $164.00 price objective on the stock. Finally, Guggenheim began coverage on Johnson & Johnson in a research report on Tuesday, February 28th. They issued a “neutral” rating and a $161.00 price objective on the stock. Seven research analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $173.00.
Insider Buying and Selling at Johnson & Johnson
Johnson & Johnson Trading Down 1.4 %
NYSE JNJ opened at $154.41 on Friday. The company has a quick ratio of 0.85, a current ratio of 1.07 and a debt-to-equity ratio of 0.49. Johnson & Johnson has a twelve month low of $150.11 and a twelve month high of $183.35. The firm has a market capitalization of $401.27 billion, a PE ratio of 32.30, a P/E/G ratio of 2.67 and a beta of 0.53. The stock’s 50 day moving average is $159.89 and its 200 day moving average is $165.86.
Johnson & Johnson (NYSE:JNJ – Get Rating) last announced its quarterly earnings data on Tuesday, April 18th. The company reported $2.68 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.51 by $0.17. The business had revenue of $24.75 billion during the quarter, compared to analysts’ expectations of $23.61 billion. Johnson & Johnson had a return on equity of 36.13% and a net margin of 13.22%. The firm’s quarterly revenue was up 5.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.67 earnings per share. Research analysts forecast that Johnson & Johnson will post 10.66 earnings per share for the current fiscal year.
Johnson & Johnson Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 6th. Shareholders of record on Tuesday, May 23rd will be paid a dividend of $1.19 per share. This is a boost from Johnson & Johnson’s previous quarterly dividend of $1.13. The ex-dividend date is Monday, May 22nd. This represents a $4.76 dividend on an annualized basis and a yield of 3.08%. Johnson & Johnson’s payout ratio is presently 99.58%.
Johnson & Johnson Profile
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and MedTech. The Consumer Health segment includes products focused on personal healthcare used in the Skin Health/Beauty, Over-the-Counter medicines, Baby Care, Oral Care, Women’s Health and Wound Care markets.
- Get a free copy of the StockNews.com research report on Johnson & Johnson (JNJ)
- 3 Electrical Gear Makers: Hidden Gems Amid Growing Digitization
- Can ULTA’s Defensive Product Line Stand Against This Down Cycle
- A Reversal Is Brewing For Medtronic: Buying The Dip
- Ralph Lauren’s Styled Dividend Is Still In Season
- Dollar Tree Falls As Theft Cuts Into Bottom Line
Want to see what other hedge funds are holding JNJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ – Get Rating).
Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.